CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-27 | Kelly James Patrick EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2019-02-27 | Birznieks Gunther SVP, Business Development | Grant or award | +30,000 | 163,780 | ||
| 2019-02-27 | Birznieks Gunther SVP, Business Development | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2019-01-03 | Birznieks Gunther SVP, Business Development | Sale | −1,619 | $26.09 | $42K | 133,780 |
| 2019-01-03 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −1,619 | $26.09 | $42K | 193,473 |
| 2019-01-03 | Polymeropoulos Mihael Hristos President and CEO | Sale | −4,447 | $26.04 | $116K | 1,163,636 |
| 2019-01-02 | Reverberi Gian Piero SVP & Chief Commercial Officer | Sale | −600 | $26.28 | $16K | 139,400 |
| 2019-01-02 | Reverberi Gian Piero SVP & Chief Commercial Officer | Sale | −530 | $26.94 | $14K | 138,870 |
| 2019-01-02 | Birznieks Gunther SVP, Business Development | Sale | −3,272 | $26.30 | $86K | 136,569 |
| 2019-01-02 | Birznieks Gunther SVP, Business Development | Sale | −1,170 | $26.95 | $32K | 135,399 |
| 2019-01-02 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −3,313 | $26.31 | $87K | 196,221 |
| 2019-01-02 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −1,129 | $26.94 | $30K | 195,092 |
| 2019-01-02 | Polymeropoulos Mihael Hristos President and CEO | Sale | −7,733 | $26.32 | $204K | 1,171,139 |
| 2019-01-02 | Polymeropoulos Mihael Hristos President and CEO | Sale | −3,056 | $26.93 | $82K | 1,168,083 |
| 2018-12-24 | Polymeropoulos Mihael Hristos President and CEO | Gift | −4,000 | 1,178,872 | ||
| 2018-08-13 | Williams Timothy SVP & General Counsel | Grant or award | +30,000 | 30,000 | ||
| 2018-08-13 | Williams Timothy SVP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2018-06-13 | COLA MICHAEL F Director | Grant or award | +5,000 | 10,000 | ||
| 2018-06-13 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-13 | DUGAN RICHARD W Director | Grant or award | +5,000 | 30,770 |
Page 18 of 20 · 387 trades